UNSPSC 51442442: Ioversol

This classification denotes an iodinated contrast dye with the molecular formula C18H24I3N3O9, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier N3RIB7X24K, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)(2-hydroxyethyl)amino)-2,4,6-triiodo- but more generally known as ioversol, which bears U.S. National Institutes of Health Compound Identifier 3741. European Medicines Agency schedules Ioversol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08262MIG.

UNSPSC 51442442 Ioversol is a Commodity code that encompasses contrast media and related diagnostic imaging agents. Recent state and local solicitations under this code show minimal direct procurement activity for ioversol itself; the two most recent opportunities tagged to this code involve X-ray system maintenance services (Broward County Aviation Department) and copper sulfate supply (Pasco County, Florida), neither of which represent core ioversol purchasing. The mismatch suggests this code sees little relevant state and local procurement activity at present, or that issuing bodies are tagging unrelated commodities to it inconsistently. When ioversol procurement does occur in state and local healthcare and emergency-response settings, it typically flows through established medical supply contracts, group purchasing organizations, or hospital system frameworks rather than standalone competitive solicitations.

Broward County Aviation Department issued a Request for Information on June 25, 2026, closing July 28, 2026, regarding maintenance services for Rapiscan X-ray systems—a sole-source inquiry unrelated to ioversol. Pasco County, Florida posted an RFQ on June 3, 2026, closing June 26, 2026, for copper sulfate crystals and liquid copper sulfate on an as-needed basis, also outside the scope of diagnostic contrast media. Geographic activity in recent records is limited to Florida counties. The absence of direct ioversol solicitations in the recent state and local record, combined with the tagging mismatches in the two posted opportunities, indicates minimal procurement momentum under this code currently. Firms pursuing contrast-media supply relationships with state and local healthcare systems should monitor hospital system RFPs and group purchasing cooperative announcements rather than expect standalone UNSPSC-tagged solicitations under this commodity code.